Current Gene Therapy
Title:Meet Our Associate Board Member
Volume: 18 Issue: 4
Author(s): Manish Mishra
Affiliation:
Export Options
About this article
Cite this article as:
Mishra Manish , Meet Our Associate Board Member, Current Gene Therapy 2018; 18 (4) . https://dx.doi.org/10.2174/156652321804181004111544
DOI https://dx.doi.org/10.2174/156652321804181004111544 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Chemistry and Pharmacological Properties of Some Natural and Synthetic Antioxidants for Heavy Metal Toxicity
Current Medicinal Chemistry Reversal of Informational Entropy and the Acquisition of Germ-like Immortality by Somatic Cells
Current Aging Science Recent Advancement of Polymersomes as Drug Delivery Carrier
Current Pharmaceutical Design HDL-Related Mechanisms of Olive Oil Protection in Cardiovascular Disease
Current Vascular Pharmacology The Blood-Brain Barrier as a Cause of Obesity
Current Pharmaceutical Design Clinical and Electroencephalographic Assessment of Cefepime During Treatment of Nosocomial Infections in Neurological Patients
Central Nervous System Agents in Medicinal Chemistry Retinoids as Differentiating Agents in Oncology: A Network of Interactions with Intracellular Pathways as the Basis for Rational Therapeutic Combinations
Current Pharmaceutical Design Editorial: Targeting Cerebral Vascular Injury for Intervention
Current Drug Delivery Targeting Tumor-Associated Antigens to the MHC Class I Presentation Pathway
Endocrine, Metabolic & Immune Disorders - Drug Targets Radiolabelled Probes Targeting Infection and Inflammation for Personalized Medicine
Current Pharmaceutical Design Norlichexanthone Isolated from Fungus P16 Promotes the Secretion and Expression of Adiponectin in Cultured ST-13 Adipocytes
Medicinal Chemistry Inflammasome as a New Therapeutic Target for Diabetic Complications
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery The Chemical Synthesis of Insulin: From the Past to the Present
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Leptin as Clinical Target
Recent Patents on Inflammation & Allergy Drug Discovery Current Strategies to Overcome Resistance to ALK-Inhibitor Agents
Current Drug Metabolism PET and SPECT Imaging of Tumor Biology: New Approaches Towards Oncology Drug Discovery and Development
Current Computer-Aided Drug Design Corrigendum: The Role of Statins in the Treatment of Type 2 Diabetes Mellitus: An Update
Current Pharmaceutical Design The Role of the Heme Oxygenase System in the Metabolic Syndrome
Current Pharmaceutical Design Vaccine Efficacy Denial: A Growing Concern Affecting Modern Science, and Impacting Public Health
Endocrine, Metabolic & Immune Disorders - Drug Targets A Review on the Effects of New Anti-Diabetic Drugs on Platelet Function
Endocrine, Metabolic & Immune Disorders - Drug Targets